In response to the terrible economic impact of the coronavirus pandemic, Congress came to the rescue of American companies, small and big, by authorizing an estimated $2 trillion stimulus plan, known as the Coronavirus Help, Relief, and Economic Security Act. The CARES Act, in part, recommends $349 billion in small business loans to help American companies survive during this economic crisis.
In addition to enacting the CARES Act, President Donald Trump signed into law the Coronavirus Readiness and Action Supplemental Appropriations Act, which contains a $20 million grant to the Small Company Administration Catastrophe Relief Fund to provide additional low-interest loans to business impacted by COVID-19
Like many other American organisations, marijuana business are struggling with major financial setbacks, yet they are rejected taking advantage of these SBA loans on the basis of their federal legality and their ability to adhere to “all relevant federal laws and regulations.”
The marijuana industry consists of both hemp and marijuana companies. Hemp became legal upon the enactment of the Farming Enhancement Act of 2018 (better known as the 2018 Farm Expense), which expressly eliminated the farming crop from the meaning of cannabis under the Controlled Substances Act(CSA). Although heavily regulated, hemp is no longer managed in the classic sense. Cannabis, on the other hand, stays an Arrange I substance under the CSA, which means the growing, manufacture, circulation, and possession of the plant is unlawful under federal law. While certified hemp organisations are entitled to the very same stimulus relief as companies in a lot of other markets, cannabis organisations are not.
In a declaration released quickly after the enactment of the CARES Act and of the Coronavirus Preparedness and Action Supplemental Appropriations Act, SBA spokesperson Carol Chastang explained:
Since federal law restricts the sale and distribution of marijuana, the SBA does not provide financial help to companies that are illegal under federal law. […] Companies that aren’t qualified include marijuana growers and dispensers, organisations that offer marijuana items, etc., even if the business is legal under regional or state law.
This is not a brand-new SBA position. In a 2018 Police Notification, the SBA described that neither “Direct Marijuana Organisations” nor “Indirect Marijuana Organisations” are eligible for SBA-funded help.
More just recently, the SBA released the 2019 Details Notification, in which it further clarified that cannabis businesses are not entitled to receiving cash appropriated for catastrophe relief since the CSA continues to restrict the sale, manufacture, circulation, and belongings of marijuana.
Although the 2019 Details Notice continues to expressly omit direct and indirect cannabis organisations from the loan help programs, it offers that hemp business that “develop or market CBD and CBD products stemmed from hemp would not be considered Direct Marijuana Organisations [… and] would be eligible to participate in SBA technical support programs, if business and its items are legal under state law and abide by all appropriate federal, state, and local laws and regulations” (Focus included).
Therefore, lots of companies engaged in the manufacture, distribution, sale, and marketing of hemp-derived items, including cannabidiol (CBD)- instilled items, would likewise be ineligible for these loans. As I composed in this column, the FDA, which holds authority over hemp CBD foods, dietary supplements, cosmetics, and tobacco products, in accordance with the 2018 Farm Expense, deems the sale and marketing of many of these items illegal under the Food, Drug and Cosmetics Act
Since January 2020, the marijuana industry was utilizing over 240,000 full-time workers throughout 34 states and the District of Columbia, making it one of the best job-creation devices in the country. Furthermore, marijuana business are required, under federal law, to abide by various COVID-19 procedures, such as paid sick leave protection. Due to this, the ineligibility of many cannabis business for SBA loans seems particularly inequitable. Unless the federal government reviews its current policies and raises the inconsistent and unjust constraints on the marijuana market, marijuana and hemp CBD companies, in addition to the American workforce they support, will be left in the weeds.
Nathalie Bougenies practices in the Portland workplace of Harris Bricken and was named a “2019 Increasing Star” by Super Lawyers Magazine, an honor bestowed on only 2.5%of eligible Oregon lawyers. Nathalie’s practice focuses on the regulative framework of hemp-derived CBD (” hemp CBD”) products. She is an authority on FDA enforcement, Food, Drug & Cosmetic Act and other laws and policies surrounding hemp and hemp CBD products. She likewise advises domestic and worldwide customers on the sale, circulation, marketing, labeling, importation and exportation of these products. Nathalie regularly speaks on these problems and has made national media looks, consisting of on NPR’s Market. Nathalie is likewise a regular contributor to her firm’s Canna Law Blog Site
Love ATL? Let’s make it official.
Register for our newsletter.